PDCD1 and neoplasm: These observations indicated that anti-PD-1 enhanced T cell-mediated immune responses within the testes of tumor-bearing mice, and highlighted the potential of RSV to modulate the T cell-mediated immune responses induced by anti-PD-1 treatment, suggesting a possible therapeutic strategy to mitigate the immunological effects of ICIs in testicular tissue.